OOIR: Observatory of International Research

Papers

(The H4-Index of Current Medicinal Chemistry is 34. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Meet the Editorial Board Member	232
Artificial Intelligence: the “Trait D’Union” in Different Analysis Approaches of Autism Spectrum Disorder Studies	143
Conformational and Structural Characterization of Carbohydrates and their Interactions Studied by NMR	88
Chalcogenium-AZT Derivatives: A Plausible Strategy To Tackle The RT-Inhibitors-Related Oxidative Stress While Maintaining Their Anti- HIV Properties	82
Corrigendum to: Update of the Preclinical Situation of Anticancer Platinum Complexes: Novel Design Strategies and Innovative Analytical Approaches	77
Interfering with the Reactive Cysteine Proteome in COVID-19	61
Meet the Editorial Board Member	52
Preface	51
Exploring the Anticancer Potential of Astragalin in Triple Negative Breast Cancer Cells by Attenuating Glycolytic Pathway through AMPK/mTOR	50
Analysis and Validation of Tyrosine Metabolism-related Prognostic Features for Liver Hepatocellular Carcinoma Therapy	50
Challenges of Natural Anticancer and Anti-inflammatory Agents	49
Drug Treatment of Epilepsy: From Serendipitous Discovery to Evolutionary Mechanisms	49
Naturally Occurring Xanthones; Biological Activities, Chemical Profiles and In Silico Drug Discovery	47
New Insights into the Long Non-coding RNAs Dependent Modulation of Heart Failure and Cardiac Hypertrophy: From Molecular Function to Diagnosis and Treatment	43
SGLT-2 Inhibitors: The Next-generation Treatment for Type 2 Diabetes Mellitus	42
Recent Advances in Lung Cancer Therapy Based on Nanomaterials: A Review	41
The Pivotal Role of Transient Receptor Potential Channels in Oral Physiology	40
Statins, Allies against Antibiotic Resistance?	40
Identification of Critical Genes Related to Breast Cancer with Brain Metastasis Through Bioinformatics Analysis	39
ANGPTL4-the Link Binding Lipid Metabolism and Inflammation	39
Integrating Transcriptomic Data and Mendelian Randomization Analyses Reveals Potentially Novel Sepsis-related Targets	39
Artificial Intelligence for Epigenetics: Towards Personalized Medicine	39
Revisiting the Role of B-RAF Kinase as a Therapeutic Target in Melanoma	39
Bacillus sp. Bacteriocins: Natural Weapons against Bacterial Enemies	39
Mitochondrial DNA Mutations in Colorectal Cancer Stem Cells: Implications for Tumor Dynamics and Therapeutic Strategies	38

Potential Therapeutic Targets for the Management of Diabetes Mellitus Type 2	38
Multimodality Cardiac Imaging Biomarkers and Atrial Fibrillation Substrate: Are they Worthwhile?	38
Detection of Prostate Cancer Biomarker PCA3 by Using Aptasensors	37
An Updated Review Deciphering Apigenin Nanostructures as Promising Therapeutic Efficiency in Human Carcinomas	37
Activating Protein-1 (AP-1): A Promising Target for the Treatment of Fibrotic Diseases	37
Ganaxolone: First FDA-approved Medicine for the Treatment of Seizures Associated with Cyclin-dependent Kinase-like 5 Deficiency Disorder	36
Serine Protease 27, a Prognostic Biomarker in Pan-cancer and Associated with the Aggressive Progression of Breast Cancer	35
Long Non-coding RNA DLGAP1-AS1 and DLGAP1-AS2: Two Novel Oncogenes in Multiple Cancers	34
Resveratrol Inhibits Hepatocellular Carcinoma Progression through Regulating Exosome Secretion	34